Identification and characterization of potential impurities of rabeprazole sodium

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 4, 2007, Pages 1262-1269

  Reddy, Ganta Madhusudhan ^a,c   Bhaskar, B Vijaya ^a   Reddy, P Pratap ^a   Sudhakar, P ^b   Babu, J Moses ^b   Vyas, K ^b   Reddy, P Ramachandra ^a   Mukkanti, K ^c  

^a Research and Development   (India)

^b DR REDDY'S LABORATORIES LTD   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Identification and characterisation; Impurities; Rabeprazole sodium; Spectroscopy

Indexed keywords

2 [[[4 (3 METHOXYPROPOXY) 3 METHYL 2 PYRIDIN 1 OXIDE]METHYL]SULFINYL] 1H BENZIMIDAZOLE; 2 [[[4 (3 METHOXYPROPOXY) 3 METHYL 2 PYRIDINYL 1 OXIDE]METHYL]SULFONYL] 1H BENZIMIDAZOLE; 2 [[[4 (3 METHOXYPROPOXY) 3 METHYL 2 PYRIDINYL]METHYL]SULFONYL] 1H BENZIMIDAZOLE; 2 [[[4 (3 METHOXYPROPOXY) 3 METHYL 2 PYRIDINYL]METHYL]THIO] 1H BENZIMIDAZOLE; 2 [[[4 (3 METHOXYPROPOXY) 3 METHYL]PYRIDINYL 2 YL]METHANESULFINYL] 1 [[4 (3 METHOXYPROPOXY) 3 METHYL]PYRIDIN 2 YLMETHYL] 1H BENZIMIDAZOLE; 2 [[[4 METHOXY 3 METHYL 2 PYRIDINYL]METHYL]SULFINYL] 1H BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; RABEPRAZOLE; UNCLASSIFIED DRUG;

ARTICLE; DRUG IMPURITY; DRUG PURITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 33847129716     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.10.017     Document Type: Article

References (9)

1. Morri M., and Takeguchi N. J. Biol. Chem. 268 (1993) 21553-21559
2. Fujisaki H., Shibata H., Oketani K., Murakami M., Fujimoto M., Wakabayashi T., Yamatsu I., Yamaguchi M., Sakai H., and Takeguchi N. Biochem. Pharmacol. 42 (1991) 321-328
3. Takeguchi N., Yamanouchi T., Sakai H., and Mora M. Jpn. J. Physiol. 42 (1992) 75-88
4. Nakai H., Shimamura Y., Kanazawa T., Yasuda S., and Kayano M. J. Chromatogr. B 660 (1994) 211-220
5. Fujisaki H., Shibata H., Oketani K., and Murakami M. Drug Invest. 3 (1991) 328-332
6. Morri M., and Takeguchi N. J. Biol. Chem. 268 (1993) 21553-21559
7. 3A (R1), current step 4 version, dated 7 February 2002.
8. Pingili R.R., Jambula M.R., Ganta M.R., Ghanta M.R., Sajja E., Sundaram V., and Boluggdu V.B. Pharmazie 60 (2005) 814-818
9. Make: MDS SCIEX, Vendor name: Applied Biosystems, Address: 850, incon Centre Drive, Foster City, California, Country, USA.